{"id":5410,"date":"2025-07-03T20:45:26","date_gmt":"2025-07-03T20:45:26","guid":{"rendered":"https:\/\/www.podermexico.mx\/?p=5410"},"modified":"2025-07-03T20:45:27","modified_gmt":"2025-07-03T20:45:27","slug":"impulsan-inversion-historica-en-industria-farmaceutica-sumado-al-plan-mexico","status":"publish","type":"post","link":"https:\/\/www.podermexico.mx\/?p=5410","title":{"rendered":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Cuatro empresas nacionales del sector farmac\u00e9utico invertir\u00e1n <strong>10,480 millones de pesos<\/strong> en infraestructura, innovaci\u00f3n y producci\u00f3n de medicamentos, como parte del <strong>Plan M\u00e9xico<\/strong>, estrategia impulsada por el gobierno federal para reducir la dependencia de insumos importados y consolidar la <strong>autosuficiencia sanitaria<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El anuncio fue encabezado por la presidenta <strong>Claudia Sheinbaum<\/strong>, quien subray\u00f3 que el pa\u00eds \u201c<strong>no puede seguir dependiendo de un solo fabricante en el mundo<\/strong>\u201d para abastecerse de medicamentos. La mandataria explic\u00f3 que las pr\u00f3ximas licitaciones p\u00fablicas priorizar\u00e1n a las empresas que produzcan en territorio nacional, con el objetivo de fortalecer la cadena de suministro y garantizar el acceso a tratamientos esenciales.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Entre los proyectos presentados destaca el de <strong>Laboratorios Kener<\/strong>, que destinar\u00e1 <strong>5,180 millones de pesos<\/strong> a la expansi\u00f3n de su planta en el Estado de M\u00e9xico. El plan incluye un centro de mezclas, una nueva l\u00ednea de inyectables hospitalarios y la instalaci\u00f3n de una unidad de producci\u00f3n de <strong>c\u00e9lulas CAR-T de tercera generaci\u00f3n<\/strong>, \u00fanica en Am\u00e9rica Latina.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Por su parte, <strong>Genbio<\/strong> anunci\u00f3 una inversi\u00f3n de <strong>4,000 millones de pesos<\/strong> para ampliar la primera planta de <strong>fraccionamiento de plasma humano<\/strong> en la regi\u00f3n, con capacidad para producir alb\u00famina, inmunoglobulinas y factores de coagulaci\u00f3n. La empresa ya ha invertido 2,400 millones en infraestructura y tecnolog\u00eda, y prev\u00e9 generar empleos especializados en biotecnolog\u00eda.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El grupo <strong>Alpharma-Biogentec<\/strong>, perteneciente a Neolpharma, present\u00f3 una inversi\u00f3n proyectada de <strong>6,000 millones de pesos<\/strong> en ocho iniciativas, entre ellas el desarrollo de <strong>biof\u00e1rmacos y vacunas<\/strong> en colaboraci\u00f3n con universidades mexicanas. En tanto, <strong>NeolSyM<\/strong> invertir\u00e1 <strong>500 millones de pesos<\/strong> en la producci\u00f3n nacional de <strong>ingredientes farmac\u00e9uticos activos (API)<\/strong>, con plantas en Morelos y el Estado de M\u00e9xico.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El secretario de Econom\u00eda, <strong>Marcelo Ebrard<\/strong>, calific\u00f3 el anuncio como un paso decisivo hacia una \u201c<strong>soberan\u00eda farmac\u00e9utica real<\/strong>\u201d, recordando que durante la pandemia de COVID-19 M\u00e9xico enfrent\u00f3 limitaciones cr\u00edticas por depender del exterior. \u201cTenemos la plataforma para crecer cuatro o cinco veces en esta administraci\u00f3n\u201d, afirm\u00f3.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cuatro empresas nacionales del sector farmac\u00e9utico invertir\u00e1n 10,480 millones de pesos en infraestructura, innovaci\u00f3n y producci\u00f3n de medicamentos, como parte del Plan M\u00e9xico, estrategia impulsada por el gobierno federal para reducir la dependencia de insumos importados y consolidar la autosuficiencia sanitaria. El anuncio fue encabezado por la presidenta Claudia Sheinbaum, quien subray\u00f3 que el pa\u00eds \u201cno puede seguir dependiendo de &hellip;<\/p>\n","protected":false},"author":7,"featured_media":5411,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[68],"tags":[1563,1416],"class_list":["post-5410","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud","tag-farmaceutica","tag-gobierno-de-mexico"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Poder M\u00e9xico\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.podermexico.mx\/?p=5410\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_MX\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Poder M\u00e9xico - Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico\" \/>\n\t\t<meta property=\"og:description\" content=\"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.podermexico.mx\/?p=5410\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-07-03T20:45:26+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-07-03T20:45:27+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#blogposting\",\"name\":\"Impulsan inversi\\u00f3n hist\\u00f3rica en industria farmac\\u00e9utica sumado al Plan M\\u00e9xico - Poder M\\u00e9xico\",\"headline\":\"Impulsan inversi\\u00f3n hist\\u00f3rica en industria farmac\\u00e9utica sumado al Plan M\\u00e9xico\",\"author\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2025-07-03_Conferencia_de_prensa_matutina_-_Palacio_Nacional_10_GM.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"Cuauht\\u00e9moc, Ciudad de M\\u00e9xico. 3 de julio 2025. La presidenta constitucional de los Estados Unidos Mexicanos, la Doctora Claudia Sheinbaum Pardo en conferencia de prensa matutina en el sal\\u00f3n de la Tesorer\\u00eda de Palacio Nacional. La acompa\\u00f1an: David Kershenobich, secretario de salud; Marcelo Ebrard Casub\\u00f3n, secretario de Econom\\u00eda; Federico Prince, director general de Labarotarios Kener; Jos\\u00e9 Miguel Ramos, Grupo Gembio; Efr\\u00e9n Ocampo L\\u00f3pez, presidente ejecutivo del Grupo Neolpharma; Diego Antonio Ocampo Guti\\u00e9rrez de Velasco, director Innovaci\\u00f3n de Neolpharma; Luz Elena Guti\\u00e9rrez de Velasco, vicepresidenta del Grupo Neolpharma y Noem\\u00ed Ju\\u00e1rez P\\u00e9rez, subsecretaria de Educaci\\u00f3n P\\u00fablica. Foto: Gabriel Monroy\\\/Presidencia\"},\"datePublished\":\"2025-07-03T20:45:26-06:00\",\"dateModified\":\"2025-07-03T20:45:27-06:00\",\"inLanguage\":\"es-MX\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#webpage\"},\"articleSection\":\"Salud, Farmac\\u00e9utica, Gobierno de M\\u00e9xico\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.podermexico.mx\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68#listItem\",\"name\":\"Salud\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68#listItem\",\"position\":2,\"name\":\"Salud\",\"item\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#listItem\",\"name\":\"Impulsan inversi\\u00f3n hist\\u00f3rica en industria farmac\\u00e9utica sumado al Plan M\\u00e9xico\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#listItem\",\"position\":3,\"name\":\"Impulsan inversi\\u00f3n hist\\u00f3rica en industria farmac\\u00e9utica sumado al Plan M\\u00e9xico\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68#listItem\",\"name\":\"Salud\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\",\"name\":\"Poder M\\u00e9xico\",\"description\":\"Donde los l\\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\\u00edtica y los negocios\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7\",\"name\":\"Poder M\\u00e9xico\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6873d270747c7f511ab0e491b4ef59ff185c68a5912118c90f83cdcd498e434b?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Poder M\\u00e9xico\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#webpage\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410\",\"name\":\"Impulsan inversi\\u00f3n hist\\u00f3rica en industria farmac\\u00e9utica sumado al Plan M\\u00e9xico - Poder M\\u00e9xico\",\"description\":\"Empresas farmac\\u00e9uticas mexicanas invertir\\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\\u00e1rmacos y reducir la dependencia de insumos importados\",\"inLanguage\":\"es-MX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2025-07-03_Conferencia_de_prensa_matutina_-_Palacio_Nacional_10_GM.jpg\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410\\\/#mainImage\",\"width\":1500,\"height\":1000,\"caption\":\"Cuauht\\u00e9moc, Ciudad de M\\u00e9xico. 3 de julio 2025. La presidenta constitucional de los Estados Unidos Mexicanos, la Doctora Claudia Sheinbaum Pardo en conferencia de prensa matutina en el sal\\u00f3n de la Tesorer\\u00eda de Palacio Nacional. La acompa\\u00f1an: David Kershenobich, secretario de salud; Marcelo Ebrard Casub\\u00f3n, secretario de Econom\\u00eda; Federico Prince, director general de Labarotarios Kener; Jos\\u00e9 Miguel Ramos, Grupo Gembio; Efr\\u00e9n Ocampo L\\u00f3pez, presidente ejecutivo del Grupo Neolpharma; Diego Antonio Ocampo Guti\\u00e9rrez de Velasco, director Innovaci\\u00f3n de Neolpharma; Luz Elena Guti\\u00e9rrez de Velasco, vicepresidenta del Grupo Neolpharma y Noem\\u00ed Ju\\u00e1rez P\\u00e9rez, subsecretaria de Educaci\\u00f3n P\\u00fablica. Foto: Gabriel Monroy\\\/Presidencia\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5410#mainImage\"},\"datePublished\":\"2025-07-03T20:45:26-06:00\",\"dateModified\":\"2025-07-03T20:45:27-06:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#website\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/\",\"name\":\"Poder M\\u00e9xico\",\"description\":\"Donde los l\\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\\u00edtica y los negocios\",\"inLanguage\":\"es-MX\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico","description":"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados","canonical_url":"https:\/\/www.podermexico.mx\/?p=5410","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.podermexico.mx\/?p=5410#blogposting","name":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico","headline":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico","author":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"publisher":{"@id":"https:\/\/www.podermexico.mx\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.podermexico.mx\/wp-content\/uploads\/2025\/07\/2025-07-03_Conferencia_de_prensa_matutina_-_Palacio_Nacional_10_GM.jpg","width":1500,"height":1000,"caption":"Cuauht\u00e9moc, Ciudad de M\u00e9xico. 3 de julio 2025. La presidenta constitucional de los Estados Unidos Mexicanos, la Doctora Claudia Sheinbaum Pardo en conferencia de prensa matutina en el sal\u00f3n de la Tesorer\u00eda de Palacio Nacional. La acompa\u00f1an: David Kershenobich, secretario de salud; Marcelo Ebrard Casub\u00f3n, secretario de Econom\u00eda; Federico Prince, director general de Labarotarios Kener; Jos\u00e9 Miguel Ramos, Grupo Gembio; Efr\u00e9n Ocampo L\u00f3pez, presidente ejecutivo del Grupo Neolpharma; Diego Antonio Ocampo Guti\u00e9rrez de Velasco, director Innovaci\u00f3n de Neolpharma; Luz Elena Guti\u00e9rrez de Velasco, vicepresidenta del Grupo Neolpharma y Noem\u00ed Ju\u00e1rez P\u00e9rez, subsecretaria de Educaci\u00f3n P\u00fablica. Foto: Gabriel Monroy\/Presidencia"},"datePublished":"2025-07-03T20:45:26-06:00","dateModified":"2025-07-03T20:45:27-06:00","inLanguage":"es-MX","mainEntityOfPage":{"@id":"https:\/\/www.podermexico.mx\/?p=5410#webpage"},"isPartOf":{"@id":"https:\/\/www.podermexico.mx\/?p=5410#webpage"},"articleSection":"Salud, Farmac\u00e9utica, Gobierno de M\u00e9xico"},{"@type":"BreadcrumbList","@id":"https:\/\/www.podermexico.mx\/?p=5410#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx#listItem","position":1,"name":"Home","item":"https:\/\/www.podermexico.mx","nextItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=68#listItem","name":"Salud"}},{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=68#listItem","position":2,"name":"Salud","item":"https:\/\/www.podermexico.mx\/?cat=68","nextItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?p=5410#listItem","name":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?p=5410#listItem","position":3,"name":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico","previousItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=68#listItem","name":"Salud"}}]},{"@type":"Organization","@id":"https:\/\/www.podermexico.mx\/#organization","name":"Poder M\u00e9xico","description":"Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","url":"https:\/\/www.podermexico.mx\/"},{"@type":"Person","@id":"https:\/\/www.podermexico.mx\/?author=7#author","url":"https:\/\/www.podermexico.mx\/?author=7","name":"Poder M\u00e9xico","image":{"@type":"ImageObject","@id":"https:\/\/www.podermexico.mx\/?p=5410#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/6873d270747c7f511ab0e491b4ef59ff185c68a5912118c90f83cdcd498e434b?s=96&d=mm&r=g","width":96,"height":96,"caption":"Poder M\u00e9xico"}},{"@type":"WebPage","@id":"https:\/\/www.podermexico.mx\/?p=5410#webpage","url":"https:\/\/www.podermexico.mx\/?p=5410","name":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico","description":"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados","inLanguage":"es-MX","isPartOf":{"@id":"https:\/\/www.podermexico.mx\/#website"},"breadcrumb":{"@id":"https:\/\/www.podermexico.mx\/?p=5410#breadcrumblist"},"author":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"creator":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.podermexico.mx\/wp-content\/uploads\/2025\/07\/2025-07-03_Conferencia_de_prensa_matutina_-_Palacio_Nacional_10_GM.jpg","@id":"https:\/\/www.podermexico.mx\/?p=5410\/#mainImage","width":1500,"height":1000,"caption":"Cuauht\u00e9moc, Ciudad de M\u00e9xico. 3 de julio 2025. La presidenta constitucional de los Estados Unidos Mexicanos, la Doctora Claudia Sheinbaum Pardo en conferencia de prensa matutina en el sal\u00f3n de la Tesorer\u00eda de Palacio Nacional. La acompa\u00f1an: David Kershenobich, secretario de salud; Marcelo Ebrard Casub\u00f3n, secretario de Econom\u00eda; Federico Prince, director general de Labarotarios Kener; Jos\u00e9 Miguel Ramos, Grupo Gembio; Efr\u00e9n Ocampo L\u00f3pez, presidente ejecutivo del Grupo Neolpharma; Diego Antonio Ocampo Guti\u00e9rrez de Velasco, director Innovaci\u00f3n de Neolpharma; Luz Elena Guti\u00e9rrez de Velasco, vicepresidenta del Grupo Neolpharma y Noem\u00ed Ju\u00e1rez P\u00e9rez, subsecretaria de Educaci\u00f3n P\u00fablica. Foto: Gabriel Monroy\/Presidencia"},"primaryImageOfPage":{"@id":"https:\/\/www.podermexico.mx\/?p=5410#mainImage"},"datePublished":"2025-07-03T20:45:26-06:00","dateModified":"2025-07-03T20:45:27-06:00"},{"@type":"WebSite","@id":"https:\/\/www.podermexico.mx\/#website","url":"https:\/\/www.podermexico.mx\/","name":"Poder M\u00e9xico","description":"Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","inLanguage":"es-MX","publisher":{"@id":"https:\/\/www.podermexico.mx\/#organization"}}]},"og:locale":"es_MX","og:site_name":"Poder M\u00e9xico - Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","og:type":"article","og:title":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico","og:description":"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados","og:url":"https:\/\/www.podermexico.mx\/?p=5410","article:published_time":"2025-07-03T20:45:26+00:00","article:modified_time":"2025-07-03T20:45:27+00:00","twitter:card":"summary_large_image","twitter:title":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico - Poder M\u00e9xico","twitter:description":"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados"},"aioseo_meta_data":{"post_id":"5410","title":null,"description":"Empresas farmac\u00e9uticas mexicanas invertir\u00e1n 10,480 mdp para ampliar infraestructura, producir biof\u00e1rmacos y reducir la dependencia de insumos importados","keywords":null,"keyphrases":{"focus":{"keyphrase":"inversi\u00f3n farmac\u00e9utica M\u00e9xico","score":32,"analysis":{"keyphraseInTitle":{"score":3,"maxScore":9,"error":1},"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":6,"maxScore":9,"error":1,"length":6},"keyphraseInURL":{"score":1,"maxScore":5,"error":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInSubHeadings":[],"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-07-03 20:45:27","updated":"2025-07-13 06:49:02","seo_analyzer_scan_date":null,"focus_keyword":"inversi\u00f3n farmac\u00e9utica M\u00e9xico","additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.podermexico.mx\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.podermexico.mx\/?cat=68\" title=\"Salud\">Salud<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tImpulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.podermexico.mx"},{"label":"Salud","link":"https:\/\/www.podermexico.mx\/?cat=68"},{"label":"Impulsan inversi\u00f3n hist\u00f3rica en industria farmac\u00e9utica sumado al Plan M\u00e9xico","link":"https:\/\/www.podermexico.mx\/?p=5410"}],"_links":{"self":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/5410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5410"}],"version-history":[{"count":1,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/5410\/revisions"}],"predecessor-version":[{"id":5412,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/5410\/revisions\/5412"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/media\/5411"}],"wp:attachment":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}